$SCND
SCIENTIFIC INDUSTRIES INC Stock $scnd

$scnd Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000165495424003937 Filed on March 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$2.484M	$2.738M	$11.11M
YoY Change	-11.47%	6.63%	-2.53%
Cost Of Revenue	$1.443M	$1.505M	$6.010M
YoY Change	-1.68%	-5.86%	6.1%
Gross Profit	$1.041M	$1.233M	$5.102M
YoY Change	-22.21%	27.24%	-11.06%
Gross Profit Margin	41.91%	45.03%	45.92%
Selling, General & Admin	$2.420M	$2.379M	$10.80M
YoY Change	-19.72%	-5.75%	6.6%
% of Gross Profit	232.48%	192.98%	211.6%
Research & Development	$710.7K	$1.194M	$3.566M
YoY Change	-10.21%	42.91%	24.12%
% of Gross Profit	68.28%	96.86%	69.9%
Depreciation & Amortization	$188.1K	$187.3K	$754.0K
YoY Change	0.11%	-2.4%	9.56%
% of Gross Profit	18.07%	15.19%	14.78%
Operating Expenses	$3.130M	$3.574M	$14.36M
YoY Change	-17.74%	6.35%	10.47%
Operating Profit	-$2.090M	-$2.341M	-$9.260M
YoY Change	-15.32%	-2.12%	27.48%
Interest Expense	$42.20K	$41.80K	$107.2K
YoY Change	348.94%		38.68%
% of Operating Profit
Other Income/Expense, Net	$37.90K	-$32.80K	$62.90K
YoY Change	-60.4%	-141.57%	-89.84%
Pretax Income	-$2.052M	-$2.332M	-$9.090M
YoY Change	-13.5%	-1.36%	29.82%
Income Tax	$0.00	-$108.8K	$0.00
% Of Pretax Income
Net Earnings	-$2.052M	-$2.223M	-$9.087M
YoY Change	-13.45%	-20.25%	60.98%
Net Earnings / Revenue	-82.61%	-81.18%	-81.78%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.20	-$0.29	-$0.90
COMMON SHARES
Basic Shares Outstanding	10.50M shares	7.004M shares
Diluted Shares Outstanding	10.44M shares		10.15M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.757M	$5.725M	$5.725M
YoY Change	6.69%	-7.65%	-38.86%
Cash & Equivalents	$351.7K	$796.1K	$796.1K
Short-Term Investments	$4.405M	$4.929M	$4.929M
Other Short-Term Assets	$468.8K	$413.5K	$413.5K
YoY Change	-3.64%	-9.48%	-24.52%
Inventory	$4.868M	$4.884M	$4.884M
Prepaid Expenses
Receivables	$1.145M	$1.157M	$1.157M
Other Receivables	$161.4K	$161.4K	$161.4K
Total Short-Term Assets	$11.40M	$12.34M	$12.34M
YoY Change	-0.64%	-5.0%	-24.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.050M	$2.356M	$2.356M
YoY Change	-9.89%	-7.12%	-5.03%
Goodwill	$115.3K	$115.3K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$716.8K
YoY Change
Other Assets	$59.40K	$668.4K	$668.4K
YoY Change	2.06%	0.63%	-82.44%
Total Long-Term Assets	$4.147M	$4.390M	$4.390M
YoY Change	-15.22%	-13.57%	-65.6%
TOTAL ASSETS
Total Short-Term Assets	$11.40M	$12.34M	$12.34M
Total Long-Term Assets	$4.147M	$4.390M	$4.390M
Total Assets	$15.55M	$16.73M	$16.73M
YoY Change	-5.0%	-7.41%	-42.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$767.4K	$711.7K	$711.7K
YoY Change	-20.94%	-19.79%	-35.65%
Accrued Expenses	$887.4K	$1.102M	$1.102M
YoY Change	-6.9%	0.3%	0.61%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.050M	$1.837M	$1.837M
YoY Change	-4.12%	-13.35%	-17.62%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$877.0K	$1.008M	$1.008M
YoY Change	-24.19%	-12.84%	-18.7%
Total Long-Term Liabilities	$877.0K	$1.008M	$1.008M
YoY Change	-24.19%	-12.84%	-18.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.050M	$1.837M	$1.837M
Total Long-Term Liabilities	$877.0K	$1.008M	$1.008M
Total Liabilities	$2.927M	$2.845M	$2.845M
YoY Change	-11.17%	-13.17%	-18.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$29.54M	-$27.49M
YoY Change	42.21%	49.39%
Common Stock	$42.20M	$41.35M
YoY Change	11915.23%	11674.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$12.62M	$13.89M	$13.89M
YoY Change
Total Liabilities & Shareholders Equity	$15.55M	$16.73M	$16.73M
YoY Change	-5.0%	-7.41%	-42.37%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.052M	-$2.223M	-$9.087M
YoY Change	-13.45%	-20.25%	60.98%
Depreciation, Depletion And Amortization	$188.1K	$187.3K	$754.0K
YoY Change	0.11%	-2.4%	9.56%
Cash From Operating Activities	-$1.565M	-$1.333M	-$6.155M
YoY Change	-10.29%	-3.57%	11.67%
INVESTING ACTIVITIES
Capital Expenditures	$47.50K	$13.80K	$131.7K
YoY Change	3.71%	-85.15%	-82.62%
Acquisitions
YoY Change
Other Investing Activities	$528.1K	-$4.122M	-$603.4K
YoY Change	-43.79%	-500.25%	-79.83%
Cash From Investing Activities	$480.6K	-$4.136M	-$735.1K
YoY Change	-46.22%	-541.41%	-80.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$6.283M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$645.7K	5.738M	5.751M
YoY Change		-6930.83%	118.81%
NET CHANGE
Cash From Operating Activities	-$1.565M	-1.333M	-6.155M
Cash From Investing Activities	$480.6K	-4.136M	-735.1K
Cash From Financing Activities	$645.7K	5.738M	5.751M
Net Change In Cash	-$444.4K	268.9K	-1.139M
YoY Change	-47.58%	-150.76%	-83.01%
FREE CASH FLOW
Cash From Operating Activities	-$1.565M	-$1.333M	-$6.155M
Capital Expenditures	$47.50K	$13.80K	$131.7K
Free Cash Flow	-$1.613M	-$1.347M	-$6.287M
YoY Change	-9.94%	-8.7%	0.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000087802
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity File Number EntityFileNumber	0-6658
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2023	us-gaap	Amortization Of Rate Deferral AmortizationOfRateDeferral	51500	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Debt Instrument Term DebtInstrumentTerm	P0Y
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0	pure
	scnd	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rates ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRates	0	pure
	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0	pure
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	96586	shares
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Registrant Name EntityRegistrantName	SCIENTIFIC INDUSTRIES, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2217279
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	80 Orville Drive
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 102
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Bohemia
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11716
CY2023	dei	City Area Code CityAreaCode	631
CY2023	dei	Local Phone Number LocalPhoneNumber	567-4700
CY2023	dei	Security12g Title Security12gTitle	Common stock, $.05 par value
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	17402152	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10503599	shares
CY2023	dei	Auditor Firm AuditorFirmId	339
CY2023	dei	Auditor Name AuditorName	Mazars USA LLP
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	796100	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1927100	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2971100	usd
CY2023Q4	scnd	Available For Sales Securities Current AvailableForSalesSecuritiesCurrent	4928700	usd
CY2022Q4	scnd	Available For Sales Securities Current AvailableForSalesSecuritiesCurrent	4272100	usd
CY2022Q2	scnd	Available For Sales Securities Current AvailableForSalesSecuritiesCurrent	6391600	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	15600	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	33600	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	15600	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1157100	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1312900	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1501400	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4883900	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4859600	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	4696300	usd
CY2023Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	161400	usd
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	161400	usd
CY2022Q2	us-gaap	Income Tax Receivable IncomeTaxReceivable	161100	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	413500	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	456800	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	547600	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2022Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	200	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	12340700	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12989900	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	16269300	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1082300	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1163200	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1005600	usd
CY2023Q4	us-gaap	Goodwill Goodwill	115300	usd
CY2022Q4	us-gaap	Goodwill Goodwill	115300	usd
CY2022Q2	us-gaap	Goodwill Goodwill	115300	usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1249900	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1763000	usd
CY2022Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	2079800	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	609000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	606000	usd
CY2022Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1273900	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1373600	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1475500	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	59400	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	58200	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	62400	usd
CY2023Q4	us-gaap	Assets Assets	16730500	usd
CY2022Q4	us-gaap	Assets Assets	18069200	usd
CY2022Q2	us-gaap	Assets Assets	21007900	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	711700	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	887300	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1105900	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	777900	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	821800	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	796000	usd
CY2023Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	23600	usd
CY2022Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	134400	usd
CY2022Q2	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	29000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	324100	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	276900	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	299300	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1837300	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2120400	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2230200	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1007800	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1156200	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1239600	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2845100	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3276600	usd
CY2022Q2	us-gaap	Liabilities Liabilities	3469800	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10145211	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7023401	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7023401	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10145211	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7003599	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7003599	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	507300	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	351200	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	351200	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	40844600	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	32900800	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	31664100	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	18600	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8400	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-105600	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27485100	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18398600	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14319200	usd
CY2023Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	13885400	usd
CY2022Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	14845000	usd
CY2022Q2	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	17590500	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	19802	shares
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	19802	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	0	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	52400	usd
CY2022Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	52400	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13885400	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14792600	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17538100	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16730500	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18069200	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21007900	usd
CY2023	us-gaap	Revenues Revenues	11111500	usd
	us-gaap	Revenues Revenues	5237800	usd
CY2022	us-gaap	Revenues Revenues	11400500	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	6009500	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2919700	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	5663800	usd
CY2023	us-gaap	Gross Profit GrossProfit	5102000	usd
	us-gaap	Gross Profit GrossProfit	2318100	usd
CY2022	us-gaap	Gross Profit GrossProfit	5736700	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5417900	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2658800	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5816600	usd
CY2023	us-gaap	Selling Expense SellingExpense	5377800	usd
	us-gaap	Selling Expense SellingExpense	2349000	usd
CY2022	us-gaap	Selling Expense SellingExpense	4310800	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3566200	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1395800	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2873300	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	51500	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	4280100	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	14361900	usd
	us-gaap	Operating Expenses OperatingExpenses	6455100	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	17280800	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-9259900	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4137000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-11544100	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	62900	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	63900	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	185100	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	107200	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	0	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	77300	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	170100	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	63900	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	262400	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9089800	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4073100	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11281700	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-99200	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2490000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	2390800	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9089800	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4073100	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-13672500	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	3300	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-6300	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	4400	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9086500	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4079400	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-13668100	usd
CY2023	scnd	Unrealized Holding Gain Loss On Investment Securities Net Of Tax UnrealizedHoldingGainLossOnInvestmentSecuritiesNetOfTax	1600	usd
	scnd	Unrealized Holding Gain Loss On Investment Securities Net Of Tax UnrealizedHoldingGainLossOnInvestmentSecuritiesNetOfTax	8600	usd
CY2022	scnd	Unrealized Holding Gain Loss On Investment Securities Net Of Tax UnrealizedHoldingGainLossOnInvestmentSecuritiesNetOfTax	-10200	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	25400	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	88600	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-86200	usd
CY2023	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	27000	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	97200	usd
CY2022	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-96400	usd
CY2023	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-9059500	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-3982200	usd
CY2022	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-13764500	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.27
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.58
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.06
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2023	scnd	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-1.27
	scnd	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.58
CY2022	scnd	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-2.06
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	26224800	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-13668100	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2727200	usd
CY2022	scnd	Other Comprehensive Income Loss Foreign Currency Transactions And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionsAndTranslationAdjustmentNetOfTax	-86200	usd
CY2022	scnd	Unrealized Holding Loss On Investment Securities Net Of Tax UnrealizedHoldingLossOnInvestmentSecuritiesNetOfTax	-10200	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2350600	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17538100	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4079400	usd
	scnd	Other Comprehensive Income Loss Foreign Currency Transactions And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionsAndTranslationAdjustmentNetOfTax	88600	usd
	scnd	Unrealized Holding Gain On Investment Securities Net Of Tax UnrealizedHoldingGainOnInvestmentSecuritiesNetOfTax	8600	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1236700	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14792600	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9086500	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3638400	usd
CY2023	scnd	Fair Value Modification Of Warrants Recorded As Stock Issuance Costs FairValueModificationOfWarrantsRecordedAsStockIssuanceCosts	2112800	usd
CY2023	scnd	Warrants Issued Value WarrantsIssuedValue	161000	usd
CY2023	scnd	Other Comprehensive Income Loss Foreign Currency Transactions And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionsAndTranslationAdjustmentNetOfTax	25400	usd
CY2023	scnd	Unrealized Holding Gain On Investment Securities Net Of Tax UnrealizedHoldingGainOnInvestmentSecuritiesNetOfTax	1600	usd
CY2023	us-gaap	Treasury Stock Retired Par Value Method Amount TreasuryStockRetiredParValueMethodAmount	0	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2240100	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13885400	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9086500	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4079400	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-13668100	usd
CY2023	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	usd
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	17300	usd
CY2022	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-433800	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	51500	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	4280100	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	754000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	380800	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	688200	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2240100	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1236700	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2350600	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	161000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	92300	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	89200	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	32700	usd
CY2023	scnd	Unrealized Holding Gain Loss On Investment Securities UnrealizedHoldingGainLossOnInvestmentSecurities	-143400	usd
	scnd	Unrealized Holding Gain Loss On Investment Securities UnrealizedHoldingGainLossOnInvestmentSecurities	-18900	usd
CY2022	scnd	Unrealized Holding Gain Loss On Investment Securities UnrealizedHoldingGainLossOnInvestmentSecurities	233700	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-42500	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2490000	usd
CY2023	scnd	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets	105200	usd
	scnd	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets	103800	usd
CY2022	scnd	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets	-810200	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	119100	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	175600	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-206700	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-13100	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-733600	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1719200	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	47400	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	89400	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-207800	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	0	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-300	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	172200	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1200	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4200	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-8100	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-222400	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-191500	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	652400	usd
CY2023	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	10100	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	27300	usd
CY2022	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	180300	usd
CY2023	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-110800	usd
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	106500	usd
CY2022	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	29000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-106800	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	807900	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-107600	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-10900	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6155000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2849000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5190200	usd
CY2023	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	5314000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2404200	usd
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2709800	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	5917400	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	346200	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	5634500	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	131700	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	253000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	757600	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1500	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	67000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-735100	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1803500	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3749300	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6283200	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3000000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	532000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	272800	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	98800	usd
CY2023	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	0	usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	0	usd
CY2022	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	-321700	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5751200	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2306700	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7900	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1500	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-71300	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1131000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1044000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6704100	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1927100	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2971100	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9675200	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	796100	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1927100	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2971100	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	scnd	Record Right Of Use Assets RecordRightOfUseAssets	166400	usd
	scnd	Record Right Of Use Assets RecordRightOfUseAssets	104326	usd
CY2022	scnd	Record Right Of Use Assets RecordRightOfUseAssets	1010900	usd
CY2023	scnd	Record Lease Liabilities RecordLeaseLiabilities	166400	usd
	scnd	Record Lease Liabilities RecordLeaseLiabilities	104642	usd
CY2022	scnd	Record Lease Liabilities RecordLeaseLiabilities	1010400	usd
CY2023Q4	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	1	pure
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6155000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27485100	usd
CY2023Q4	scnd	Equity Financing EquityFinancing	6283224	usd
CY2024Q1	scnd	Equity Financing EquityFinancing	716776	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission requires management to make estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. Estimates are used for, but not limited to, the valuation allowance of net, deferred taxes. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p>
CY2023	scnd	Obligation Percentage ObligationPercentage	0.50	pure
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	166000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1082100	usd
CY2022Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1984300	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	15600	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	33600	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	15600	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4280100	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	51500	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51500	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	0	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	474200	usd
	us-gaap	Advertising Expense AdvertisingExpense	433500	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	628700	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-size:10pt;font-family:times new roman;margin:0px">Certain balances from the six months ended December 31, 2022 and for the year ended June 30, 2022 have been reclassified to conform to the current year presentation.</p>
CY2023	scnd	Description Of New Accounting Pronouncement Not Yet Adopted DescriptionOfNewAccountingPronouncementNotYetAdopted	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In June 2016, the FASB issued ASU No. 2016-13, Credit Losses-Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. The Company adopted ASU 2016-13 beginning January 1, 2023, with no material impact to its consolidated financial position or results of operations.</p>
CY2023Q4	scnd	Available For Sale Securities Current Amount AvailableForSaleSecuritiesCurrentAmount	4928700	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	4928700	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1927100	usd
CY2022Q4	scnd	Available For Sale Securities Current Amount AvailableForSaleSecuritiesCurrentAmount	4272100	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	6199200	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2971100	usd
CY2022Q2	scnd	Available For Sale Securities Current Amount AvailableForSaleSecuritiesCurrentAmount	6391600	usd
CY2022Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	9362700	usd
CY2023Q4	scnd	Cost Of Financial Instruments CostOfFinancialInstruments	4929300	usd
CY2023Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	4929300	usd
CY2023Q4	scnd	Unrealized Holding Gain Loss UnrealizedHoldingGainLoss	-600	usd
CY2022Q4	scnd	Cost Of Financial Instruments CostOfFinancialInstruments	4417400	usd
CY2022Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	4272100	usd
CY2022Q4	scnd	Unrealized Holding Gain Loss UnrealizedHoldingGainLoss	-145300	usd
CY2022Q2	scnd	Cost Of Financial Instruments CostOfFinancialInstruments	6532400	usd
CY2022Q2	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	6391600	usd
CY2022Q2	scnd	Unrealized Holding Gain Loss UnrealizedHoldingGainLoss	-140800	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3436300	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3703900	usd
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3298300	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	23200	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	66700	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	55300	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2033400	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1695000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1342700	usd
CY2023Q4	scnd	Inventory Net1 InventoryNet1	5492900	usd
CY2022Q4	scnd	Inventory Net1 InventoryNet1	5465600	usd
CY2022Q2	scnd	Inventory Net1 InventoryNet1	4696300	usd
CY2023Q4	scnd	Inventories Current Assets InventoriesCurrentAssets	4883900	usd
CY2022Q4	scnd	Inventories Current Assets InventoriesCurrentAssets	4859600	usd
CY2022Q2	scnd	Inventories Current Assets InventoriesCurrentAssets	4696300	usd
CY2023Q4	scnd	Inventories Noncurrent Assets InventoriesNoncurrentAssets	609000	usd
CY2022Q4	scnd	Inventories Noncurrent Assets InventoriesNoncurrentAssets	606000	usd
CY2022Q2	scnd	Inventories Noncurrent Assets InventoriesNoncurrentAssets	0	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2531700	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2365300	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2088700	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1449400	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1202100	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1083100	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1082300	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1163200	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1005600	usd
CY2023	us-gaap	Depreciation Depreciation	240900	usd
	us-gaap	Depreciation Depreciation	115200	usd
CY2022	us-gaap	Depreciation Depreciation	145300	usd
CY2023	scnd	Wrote Off Fully Depreciated Assets WroteOffFullyDepreciatedAssets	38600	usd
	scnd	Wrote Off Fully Depreciated Assets WroteOffFullyDepreciatedAssets	0	usd
CY2022	scnd	Wrote Off Fully Depreciated Assets WroteOffFullyDepreciatedAssets	0	usd
CY2023	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	38600	usd
	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	0	usd
CY2022	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	115300	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	513100	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	265600	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	542900	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	509600	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	371500	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	193800	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	92600	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	41800	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	40600	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1249900	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4280100	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	51500	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	51500	usd
CY2023Q4	scnd	Weighted Average Discount Rate WeightedAverageDiscountRate	0.25	pure
CY2023	scnd	Weighted Average Years WeightedAverageYears	P4Y4M6D
	scnd	Weighted Average Years WeightedAverageYears	P5Y5M1D
CY2022	scnd	Weighted Average Years WeightedAverageYears	P5Y11M1D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0543	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0500	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0500	pure
CY2023	us-gaap	Variable Lease Payment VariableLeasePayment	334600	usd
	us-gaap	Variable Lease Payment VariableLeasePayment	186000	usd
CY2022	us-gaap	Variable Lease Payment VariableLeasePayment	344500	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	387900	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	360500	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	266600	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	274600	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	201000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1490600	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	158700	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1331900	usd
CY2023	scnd	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	10145211	shares
	scnd	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	7003599	shares
CY2022	scnd	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	6637471	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10145211	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7003599	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6637471	shares
CY2023	scnd	Income Loss From Continuing Operations Per Basic And Diluted Share Continuing Operations IncomeLossFromContinuingOperationsPerBasicAndDilutedShareContinuingOperations	-1.27
	scnd	Income Loss From Continuing Operations Per Basic And Diluted Share Continuing Operations IncomeLossFromContinuingOperationsPerBasicAndDilutedShareContinuingOperations	-0.58
CY2022	scnd	Income Loss From Continuing Operations Per Basic And Diluted Share Continuing Operations IncomeLossFromContinuingOperationsPerBasicAndDilutedShareContinuingOperations	-2.06
CY2023	scnd	Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share Discontinued Operation IncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShareDiscontinuedOperation	0
	scnd	Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share Discontinued Operation IncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShareDiscontinuedOperation	0
CY2022	scnd	Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share Discontinued Operation IncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShareDiscontinuedOperation	0
CY2023	scnd	Consolidated Operations Earnings Per Share Basic And Diluted ConsolidatedOperationsEarningsPerShareBasicAndDiluted	-1.27
	scnd	Consolidated Operations Earnings Per Share Basic And Diluted ConsolidatedOperationsEarningsPerShareBasicAndDiluted	-0.58
CY2022	scnd	Consolidated Operations Earnings Per Share Basic And Diluted ConsolidatedOperationsEarningsPerShareBasicAndDiluted	-2.06
CY2022Q1	us-gaap	Stock Issued During Period Shares Period Increase Decrease StockIssuedDuringPeriodSharesPeriodIncreaseDecrease	5000000	shares
CY2022Q1	scnd	Common Stock Shares Authorized Increase CommonStockSharesAuthorizedIncrease	15000000	shares
CY2022Q1	scnd	Common Stock Shares Authorized Increase CommonStockSharesAuthorizedIncrease	20000000	shares
CY2023Q4	us-gaap	Stock Issued During Period Shares Period Increase Decrease StockIssuedDuringPeriodSharesPeriodIncreaseDecrease	20000000	shares
CY2023Q4	scnd	Common Stock Shares Authorized Increase CommonStockSharesAuthorizedIncrease	30000000	shares
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.05
CY2021Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7580400	usd
CY2021Q2	scnd	Issuence And Sold Aggregate Shares To Investors IssuenceAndSoldAggregateSharesToInvestors	1595880	shares
CY2021Q2	us-gaap	Share Price SharePrice	4.75
CY2021Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	797940	shares
CY2021Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	9.50
CY2021	scnd	Addition Proceed From Common Stock AdditionProceedFromCommonStock	9500000	usd
CY2021	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2000000	shares
CY2023	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0	pure
CY2022	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0	pure
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2240100	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1236700	usd
CY2021Q2	us-gaap	Share Price SharePrice	4.75
CY2021	scnd	Additional Common Stock Purchased Share AdditionalCommonStockPurchasedShare	999993	shares
CY2021Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	9.50
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1300000	usd
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	545456	shares
CY2022Q1	scnd	Additional Common Stock Purchased Share AdditionalCommonStockPurchasedShare	274727	shares
CY2022Q1	us-gaap	Share Price SharePrice	5.50
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3000000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	272800	usd
CY2023Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3500000	shares
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.00
CY2023Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7000000	usd
CY2023Q4	us-gaap	Share Price SharePrice	0.05
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1257331	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	559905	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	17631	shares
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	2112800	usd
CY2023	scnd	Summarizes Information About Terms Of The Outstanding Warrants SummarizesInformationAboutTermsOfTheOutstandingWarrants	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>Warrant Issue Date</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>Outstanding Warrants</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong> Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>Expiration Date</strong></p></td><td> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6/19/2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:22%;vertical-align:bottom;text-align:right;">1,034,350</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:22%;vertical-align:bottom;text-align:right;">9.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:22%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6/18/2025</p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4/30/2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">443,469</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">9.50</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4/29/2026</p></td><td> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6/21/2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">83,155</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">9.50</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6/18/2026</p></td><td> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3/2/2022</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">26,669</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">5.50</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3/2/2027</p></td><td> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/13/2023</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">5,030,407</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.50</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/13/2028</p></td><td> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/13/2023</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">131,904</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.00</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/13/2028</p></td><td> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/19/2023</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">992,840</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.50</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/19/2028</p></td><td> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/19/2023</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">21,647</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.00</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/19/2028</p></td><td> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/20/2023</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">88,232</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.50</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/20/2028</p></td><td> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/20/2023</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">3,530</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.00</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/20/2028</p></td><td> </td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">7,856,203</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td> </td></tr></tbody></table>
CY2023Q4	scnd	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber	7856203	shares
CY2023Q3	us-gaap	Other Noncash Expense OtherNoncashExpense	684900	usd
CY2023Q3	us-gaap	Legal Fees LegalFees	8000	usd
CY2023	us-gaap	Legal Fees LegalFees	19200	usd
CY2023	scnd	Granted Options GrantedOptions	35000	shares
CY2023	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	114700	usd
CY2023	us-gaap	Debt Instrument Term DebtInstrumentTerm	P10Y
CY2022	us-gaap	Debt Instrument Term DebtInstrumentTerm	P10Y
CY2023	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0449	pure
CY2022	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0191	pure
CY2023	scnd	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rates ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRates	0.725	pure
CY2022	scnd	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rates ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRates	0.72	pure
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2350600	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	450100	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1945300	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3187300	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P0Y10M13D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P1Y1M20D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P1Y6M3D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1115810	shares
CY2022Q4	scnd	Weighted Average Exercise Price Outstanding Beginning WeightedAverageExercisePriceOutstandingBeginning	8.4
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1158644	shares
CY2022Q2	scnd	Weighted Average Exercise Price Outstanding Beginning WeightedAverageExercisePriceOutstandingBeginning	8.40
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1180757	shares
CY2021Q2	scnd	Weighted Average Exercise Price Outstanding Beginning WeightedAverageExercisePriceOutstandingBeginning	8.73
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	35000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.09
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	120000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.78
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	scnd	Number Of Options Forfeited NumberOfOptionsForfeited	-30713	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.62
	scnd	Number Of Options Forfeited NumberOfOptionsForfeited	-42834	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	8.33
CY2022	scnd	Number Of Options Forfeited NumberOfOptionsForfeited	-142113	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	8.98
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1120097	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.32
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1115810	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.40
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1158644	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.40
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	963228	shares
CY2023Q4	scnd	Weighted Average Exercise Price Exercisable WeightedAverageExercisePriceExercisable	8.45
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	632175	shares
CY2022Q4	scnd	Weighted Average Exercise Price Exercisable WeightedAverageExercisePriceExercisable	8.30
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	567594	shares
CY2022Q2	scnd	Weighted Average Exercise Price Exercisable WeightedAverageExercisePriceExercisable	8.13
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.28
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.43
CY2023	us-gaap	Revenues Revenues	11111500	usd
CY2023Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	2421700	usd
	us-gaap	Revenues Revenues	5237800	usd
CY2022Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	2595000	usd
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1	pure
CY2023	us-gaap	Multiemployer Plan Contribution Rate Increase Decrease MultiemployerPlanContributionRateIncreaseDecrease	0.03	pure
CY2022	scnd	Employees Deferral Over EmployeesDeferralOver	0.50	pure
CY2023	scnd	Employees Deferral Over EmployeesDeferralOver	0.03	pure
CY2022	us-gaap	Multiemployer Plan Contribution Rate Increase Decrease MultiemployerPlanContributionRateIncreaseDecrease	0.05	pure
CY2023	us-gaap	Contribution Of Property ContributionOfProperty	122400	usd
	us-gaap	Contribution Of Property ContributionOfProperty	58600	usd
CY2022	us-gaap	Contribution Of Property ContributionOfProperty	112400	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-5352700	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-3285900	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-8985600	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-3737100	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-787200	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2296100	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9089800	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4073100	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-11281700	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-99200	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1693700	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	800300	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2394800	usd
CY2023	scnd	Provision For Income Taxes Allocated To Continuing Operations ProvisionForIncomeTaxesAllocatedToContinuingOperations	0	usd
	scnd	Provision For Income Taxes Allocated To Continuing Operations ProvisionForIncomeTaxesAllocatedToContinuingOperations	0	usd
CY2022	scnd	Provision For Income Taxes Allocated To Continuing Operations ProvisionForIncomeTaxesAllocatedToContinuingOperations	2390800	usd
CY2023	scnd	Provision For Income Taxes Allocated To Discontinued Operations ProvisionForIncomeTaxesAllocatedToDiscontinuedOperations	0	usd
	scnd	Provision For Income Taxes Allocated To Discontinued Operations ProvisionForIncomeTaxesAllocatedToDiscontinuedOperations	0	usd
CY2022	scnd	Provision For Income Taxes Allocated To Discontinued Operations ProvisionForIncomeTaxesAllocatedToDiscontinuedOperations	4000	usd
	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	1302600	usd
CY2022	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	5116000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	326600	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	426400	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	416900	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	367400	usd
CY2023Q4	scnd	Deferred Tax Assets Goodwill Impairment DeferredTaxAssetsGoodwillImpairment	898800	usd
CY2022Q4	scnd	Deferred Tax Assets Goodwill Impairment DeferredTaxAssetsGoodwillImpairment	898800	usd
CY2022Q2	scnd	Deferred Tax Assets Goodwill Impairment DeferredTaxAssetsGoodwillImpairment	898800	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1908900	usd
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-855400	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2369200	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-9400	usd
	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-49600	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-99200	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	73300	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	36600	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	64300	usd
CY2023	us-gaap	Payments For Loans PaymentsForLoans	0	usd
	us-gaap	Payments For Loans PaymentsForLoans	0	usd
CY2022	us-gaap	Payments For Loans PaymentsForLoans	91100	usd
CY2023	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	2883700	usd
	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	1302600	usd
CY2022	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	5116000	usd
CY2023	scnd	Aquila Biolabs Gmbh Operating Loss AquilaBiolabsGmbhOperatingLoss	-1150800	usd
	scnd	Aquila Biolabs Gmbh Operating Loss AquilaBiolabsGmbhOperatingLoss	-245700	usd
CY2022	scnd	Aquila Biolabs Gmbh Operating Loss AquilaBiolabsGmbhOperatingLoss	-717100	usd
CY2023	scnd	Differences Between Estimated Financial Income Tax Provision And Actual Filed Tax Return Results DifferencesBetweenEstimatedFinancialIncomeTaxProvisionAndActualFiledTaxReturnResults	112100	usd
	scnd	Differences Between Estimated Financial Income Tax Provision And Actual Filed Tax Return Results DifferencesBetweenEstimatedFinancialIncomeTaxProvisionAndActualFiledTaxReturnResults	-187800	usd
CY2022	scnd	Differences Between Estimated Financial Income Tax Provision And Actual Filed Tax Return Results DifferencesBetweenEstimatedFinancialIncomeTaxProvisionAndActualFiledTaxReturnResults	0	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	usd
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-700	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	491100	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2394800	usd
CY2023	scnd	Income Tax Expense Benefit Allocated To Continuing Operations IncomeTaxExpenseBenefitAllocatedToContinuingOperations	0	usd
	scnd	Income Tax Expense Benefit Allocated To Continuing Operations IncomeTaxExpenseBenefitAllocatedToContinuingOperations	0	usd
CY2022	scnd	Income Tax Expense Benefit Allocated To Continuing Operations IncomeTaxExpenseBenefitAllocatedToContinuingOperations	2390800	usd
CY2023	scnd	Income Tax Expense Benefit Allocated To Discontinued Operations IncomeTaxExpenseBenefitAllocatedToDiscontinuedOperations	0	usd
	scnd	Income Tax Expense Benefit Allocated To Discontinued Operations IncomeTaxExpenseBenefitAllocatedToDiscontinuedOperations	0	usd
CY2022	scnd	Income Tax Expense Benefit Allocated To Discontinued Operations IncomeTaxExpenseBenefitAllocatedToDiscontinuedOperations	4000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	106300	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	377800	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	957900	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	276900	usd
CY2022Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	103300	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	92200	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	50400	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	1486400	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	1047600	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	710500	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5383200	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3353100	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2769400	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	27200	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	57600	usd
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	52900	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9389500	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6520900	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5176000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	87200	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	102300	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	60000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9302300	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6418600	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5116000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	20154400	usd
	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	7571300	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	5961700	usd
CY2023	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	9330700	usd
	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	5645900	usd
CY2022	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	4858700	usd

Files In Submission

Name	View Source	Status
0001654954-24-003937-index-headers.html	Edgar Link	pending
0001654954-24-003937-index.html	Edgar Link	pending
0001654954-24-003937.txt	Edgar Link	pending
0001654954-24-003937-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scnd-20231231.xsd	Edgar Link	pending
scnd_10k.htm	Edgar Link	pending
scnd_ex231.htm	Edgar Link	pending
scnd_ex232.htm	Edgar Link	pending
scnd_ex311.htm	Edgar Link	pending
scnd_ex312.htm	Edgar Link	pending
scnd-20231231_def.xml	Edgar Link	unprocessable
scnd-20231231_lab.xml	Edgar Link	unprocessable
scnd-20231231_pre.xml	Edgar Link	unprocessable
scnd_10k_htm.xml	Edgar Link	completed
scnd_ex321.htm	Edgar Link	pending
scnd_ex322.htm	Edgar Link	pending
scnd_ex4h.htm	Edgar Link	pending
scnd_ex4himg1.jpg	Edgar Link	pending
Show.js	Edgar Link	pending
scnd-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCND
SCIENTIFIC INDUSTRIES INC Stock $scnd

2024 Q1 Form 10-K Financial Statement

#000165495424003937 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCND SCIENTIFIC INDUSTRIES INC Stock $scnd

2024 Q1 Form 10-K Financial Statement

#000165495424003937 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCND
SCIENTIFIC INDUSTRIES INC Stock $scnd